German biotech company Morphosys’ tafasitamab, the group’s most advanced drug which is currently being tested, has sales potential of significantly more than $1 billion a year, its finance chief said in remarks to a magazine.
International organizations warned on Friday of a potential resurgence of Ebola in Congo after deadly militia attacks on health centers forced aid groups to suspend operations and withdraw staff from the epidemic’s last strongholds.
Swiss drugmaker Novartis’s new $90 million cell and gene therapy factory in northern Switzerland is on track to begin commercial production of treatments, including Kymriah for cancer and Zolgensma for spinal muscular atrophy, in 2020.
Eleven drugmakers led by Pfizer and Novartis have set aside a combined $2 billion to invest in gene therapy manufacturing since 2018, according to a Reuters analysis, in a drive to better control production of the world’s priciest medicines.
Blackstone Group Inc said on Monday it will invest $400 million in a joint venture with Swiss drug company Ferring that is working on an experimental gene therapy for bladder cancer, the private equity giant’s largest ever bet on drug development.
Deaths related to measles, mostly among small children, have more than tripled to 20 in the past week on the Pacific island of Samoa, the government has said eight days after declaring a state of emergency over the outbreak.
Researchers in Canada have identified a new kind of vaping-related lung injury they believe is linked to flavorings in conventional vape pens, causing symptoms similar to the “popcorn lung” injury seen in workers exposed to flavorings in microwave popcorn.